본문 바로가기
bar_progress

Text Size

Close

[Click eStock] "Bioport Expected to Achieve Record-High Sales in the Second Half"

On August 20, Hanwha Investment & Securities predicted that Bioport would achieve record-high sales in the second half of this year. The company did not provide an investment opinion or target price.


Han Yoo-jung, a researcher at Hanwha Investment & Securities, stated, "Despite sluggish domestic demand and growing tariff risks, Bioport is showing a rapid recovery in sales. While quarterly margin fluctuations are inevitable due to changes in the product mix, profitability is also expected to gradually recover through cost reductions and top-line growth."


In the second quarter of this year, Bioport reported sales of KRW 19.2 billion, up 13.2% year-on-year, while operating profit fell 26% to KRW 700 million. Han explained, "The delay in new product launches led to a decrease in high-margin snack sales, resulting in a shift in the product mix. Additionally, increased logistics costs caused the operating margin to drop by 2.0 percentage points year-on-year to 3.9%. However, strong sales of newly launched products in Korea during the first half and robust exports of the flagship Yuzu Ginger Tea to the United States drove sales growth both year-on-year and quarter-on-quarter."


Record-high quarterly sales are expected in the second half. Han projected, "Third-quarter sales are expected to reach KRW 19.9 billion, up 13.4% year-on-year, and fourth-quarter sales are projected at KRW 30 billion, up 63.4%. Each quarter is expected to set new record highs. The new snack product launched in Korea in July is achieving remarkable results in a short period, and this product is scheduled to be released in Greater China (Company C), Philippine warehouse stores, and Amazon US in the second half." She added, "Exports of Yuzu Ginger Tea in the second half are expected to reach KRW 10.2 billion, continuing the growth trend from the first half."


There are also expectations that annual sales will surpass KRW 100 billion next year. Han forecasted, "With steady sales of existing bestsellers and the expansion of new products launched this year into additional countries and channels starting in earnest in 2026, their contribution to results will increase. In addition, existing products will enter new countries and channels, and annual sales in 2026 are expected to exceed KRW 100 billion."

[Click eStock] "Bioport Expected to Achieve Record-High Sales in the Second Half"


© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Special Coverage


Join us on social!

Top